2.560USD-4.48%Mkt Cap: 11.35M USDP/E: —Last update: 2026-05-22
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a poten…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Company
Market Cap11.35M USD
Enterprise Value-1.62M USD
Revenue (TTM)—
Gross Profit-3.71M USD
Net Income (TTM)-10.84M USD
Revenue/Share—
Last Price2.560 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.20
PEG—
EV/EBITDA0.16
EV/Revenue—
P/S—
P/B0.77
EPS (TTM)-2.70
EPS (Forward)-2.23
52W Range
1.76533% of range4.180
52W High4.180 USD
52W Low1.765 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-67.19%
ROA-44.67%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.96M USD
CapEx (TTM)110.79K USD
FCF Margin—
FCF Yield-84.43%
Net Debt-13.50M USD
Net Debt/EBITDA1.37
Balance Sheet
Debt/Equity0.02
Current Ratio6.68
Quick Ratio6.19
Book Value/Sh3.489 USD
Cash/Share3.130 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateAug 30, 2019
Splits
Last Split1:9
Split DateJun 11, 2024
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)12.00 USD
Target Range12.00 USD – 12.00 USD
# Analysts1
Ownership
Shares Out.4.43M
Float4.30M
Insiders3.05%
Institutions18.91%
Short Interest
Short Ratio0.0d
Short % Float0.72%
Short % Out.0.69%
Shares Short30.79K
Short (prev mo.)16.95K
Technical
SMA 502.322 (+10.2%)
SMA 2002.328 (+10.0%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)60.81K
Avg Vol (10d)59.83K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—